Teva Pharmaceutical reported 864M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Aspen Pharmacare APN:SJ 4.52B 86M
Cipla CIPLA:IN 8.78B 95.1M
Dr.Reddys Laboratories DRRD:IN 24B 748M
Guangzhou Baiy 600332:CH 2.07B 401.66M
Jiangsu Hengrui Me. 600276:CH 2.7B 181.85M
Kalbe Farma Tbk Pt KLBF:IJ 1573.29B 98.24B
Richter Gedeon RICHT:HB 34.2B 905M
Sh Fosun Pharma 600196:CH 3.25B 224.2M
Sun Pharmaceuticals SUNP:IN 18.06B 475.3M
Teva Pharmaceutical TEVA:IT 864M 32M